You are here: Industry Insights > Diabetes

News List

ADA: Teplizumab Can Delay T1DM Progression in Those at Risk drugs
June 14, 2019
Teplizumab Can Delay T1DM Progression in Those at Risk.
Type 1 Diabetes Might Affect Young Kids' Brain Development drugs
June 14, 2019
Type 1 Diabetes Might Affect Young Kids' Brain Development.
Lilly's Tirzepatide Demonstrates Benefits in Data Presented at the American Diabetes Association's® 79ᵗʰ Scientific Sessions drugs
June 13, 2019
Lilly's Tirzepatide Demonstrates Benefits in Data Presented at the American Diabetes Association's® 79ᵗʰ Scientific Sessions.
Vitamin D Supplements Don't Prevent Type 2 Diabetes: Study drugs
June 11, 2019
Vitamin D Supplements Don't Prevent Type 2 Diabetes.
Investigational Drug, Teplizumab, May Help Delay Onset of Type 1 Diabetes drugs
June 11, 2019
Investigational Drug, Teplizumab, May Help Delay Onset of Type 1 Diabetes.
What and How You Eat Affects Your Odds for Type 2 Diabetes drugs
June 10, 2019
What and How You Eat Affects Your Odds for Type 2 Diabetes.
Recent Plateauing Seen in Prevalence of Diagnosed Diabetes drugs
May 30, 2019
Recent Plateauing Seen in Prevalence of Diagnosed Diabetes.
The global GLP-1R agonist market rapidly expands PharmaSources/1℃
May 29, 2019
According to my statistical data, the global diabetes market size was around USD40 billion during 2008-2018, wherein, insulin products accounted for about 50%.
Polyethylene Glycol Loxenatide! The First Chinese-produced Long-acting GLP-1R Agonist PharmaSources/1℃
May 29, 2019
The blockbuster diabetes product: long-acting GLP-1 receptor agonist polyethylene glycol loxenatide (trade name: Fulaimei) of Hansoh Pharmaceutical has been marketed on May 7, 2019
New Gene Variants for Type 2 Diabetes Found drugs
May 24, 2019
New Gene Variants for Type 2 Diabetes Found.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page